BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
DRD2
,
nitric oxide metabolic process
,
Diabetes mellitus
,
Endothelial cell
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
IPO5;jsessionid=94539D903AF2F1500774767085203C3F
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
No tissues found
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Loading...
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Loading...
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
Loading...
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Withaferin A, a polyfunctional pharmacophore that includes covalent engagement of IPO5, is an inhibi…
Activin and BMP Signalling in Human Testicular Cancer Cell Lines, and a Role for the Nucleocytoplasm…
IPO5 promotes malignant progression of esophageal cancer through activating MMP7.
The full-length interleukin-33 (FLIL33)-importin-5 interaction does not regulate nuclear localizatio…
Quantitative Proteomics of the SMAD (Suppressor of Mothers against Decapentaplegic) Transcription Fa…
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
There were no clinical trials for IPO5;jsessionid=94539D903AF2F1500774767085203C3F
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ